Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Fidia Spa ( (IT:FDA) ) is now available.
Fidia S.p.A. has converted 10 bonds from the first tranche of its convertible bond loan with warrants reserved for Global Growth Holding Limited into 1,000,000 new shares at a price of €0.10 per share, which are being admitted directly to trading on the regulated market. Following this transaction, the company’s share capital increases by €100,000 to €9,947,761.90, bringing the total number of shares to 31,298,485, while 15 subscribed bonds remain outstanding and unconverted under the POC.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a leading global provider of numerical control technology and high-performance integrated milling systems. With more than 40 years of experience and around 135 employees, it serves primarily the mould segment for the automotive and aerospace industries, offering complete solutions from machining program definition to finished product, including controls, milling machines and CAM software.
Average Trading Volume: 977,090
Technical Sentiment Signal: Strong Sell
Current Market Cap: €3.48M
For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.

